- Congresses
- IMCAS Asia - June 2025
- IMCAS China - July 2025
- IMCAS World Congress - January 2026
- IMCAS Americas - March 2026
- IMCAS Asia - June 2026
- Masterclasses
- IMCAS India - November 2025
- Congresses
- IMCAS Asia - June 2025
- IMCAS China - July 2025
- IMCAS World Congress - January 2026
- IMCAS Americas - March 2026
- IMCAS Asia - June 2026
- Masterclasses
- IMCAS India - November 2025

IMCAS Academy

Introduction
Program
Speakers
Sponsor list
Congress map
Accreditation

GO BACK

IMCAS Academy International
Program

Adapt the schedule of the livestreamed class/congress to your time zone

Time zone reference: (UTC-04:00) America, New York

Time zone

Time zone:Change time zone

If you are logged in, change your default time zone in your account

Melasma: global therapeutic update

Partner of the session

ESLD

European Society for Laser and Energy-Based Devices

International

European Society for Laser and Energy-Based Devices

ESLD dedicates itself to dermatological procedures performed not only with means relating to photons (lasers, intense pulsed light sources and light emitting diodes) but also with means related to electrical current technology such as radiofrequency. ESLD’s priority is to guard excellence of care by teaching its members the best ways of treating patients with light and other related techniques.

Partner of the session

SOMALDEC

Société Marocaine de Lasers, Dermatologie Esthétique et Chirurgicale

Morocco

Focus program

Room: Webinar
Date: Wednesday 31 March 2021 at 11:00 to 12:30
Format: FOCUS SESSION > lectures covering a major topic of the congress

Chairs

Prof Laila BENZEKRI

Dermatologist

Morocco

Prof Philippe HUMBERT

Dermatologist

France

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
11:00	Dominique DU CREST	Introduction		108884
11:05	Dr Maya Minjin OH	Melasma and the Asian perspective	View	108887
11:17	Dr Mukta SACHDEV	How do I manage my melasma patients?		108889
11:29	Prof Manal BOSSEILA	Efficacy and safety of laser in the treatment of melasma	View	108888
11:41	Dr Seemal R DESAI	Tranexamic acid for melasma		108890
11:53		Discussion and Q&A with the audience		108891

Go to previous day (Webinar)

Go to next day (Webinar)

Dominique DU CREST

Industry Representative

France

Other author(s) :

Introduction

Dr Maya Minjin OH

Cosmetic Surgeon

South Korea

Other author(s) :

Melasma and the Asian perspective

Objectives: Melasma and the Asian perspective

Introduction: .

Materials / method: .

Results: .

Conclusion: .

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Mukta SACHDEV

Dermatologist

India

Other author(s) :

How do I manage my melasma patients?

Prof Manal BOSSEILA

Dermatologist

Egypt

Other author(s) : Noha Ghonim; Pakinam Mostafa

Efficacy and safety of laser in the treatment of melasma

Objectives: This presentation aims at comparing different fluences of Q-switched Nd:YAG (Qs
Nd:YAG) laser that can induce an effective response with best safety for melasma patients. The role of dermoscopy in assessing the therapeutic response in cases of melasma will be evaluated.

Introduction: Melasma continues to be a difficult to treat disease with no fully satisfactory results. Low-fluence 1064 nm Q-switched Nd:YAG laser has been shown to be effective for
melasma treatment.

Materials / method: In this presentation the results obtained from treating melasma patients with various fluences of Nd-Yag will be demonstrated.

Results: It is safe to assume that using conservative treatment approaches as lowering the fluence and adjusting sessions’ intervals can help optimize the therapeutic outcome and avoid complications in melasma laser toning.

Conclusion: In our experience, the melasma lesions show improvement of pigmentation in response to Qs Nd:YAG but no clearance.
Strict and continuous sun protection measures are essential for patients with melasma.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Seemal R DESAI

Dermatologist

United States

Other author(s) :

Tranexamic acid for melasma

Discussion and Q&A with the audience

You have a question?

Quickly find your answer in our FAQ

Congresses

IMCAS Asia
IMCAS China
IMCAS World Congress
IMCAS Americas
IMCAS Asia

About

Company
Privacy Policy
Legal information

Academy

Home
Courses
Webinars
Explore
Blog

Grant

Educational grant

Get in touch

Username/Email

Password

Keep me logged in

Forgot password ? Do not have an account yet? Sign up now

Keep me logged in

academy.Do_not_have_an_account_yet Sign up now

IMCAS Academy International Program

Melasma: global therapeutic update

Chairs

Lectures of the session

IMCAS Academy International
Program